These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 9302175

  • 1. Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: a seven year follow-up.
    Crundwell MC, Arkell DG, Gearty J, Phillips SM.
    J Urol; 1997 Oct; 158(4):1568-75. PubMed ID: 9302175
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R, Takahashi S, DeLacey K, Bergstralh E, Lieber M.
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [Abstract] [Full Text] [Related]

  • 3. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
    Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma VM.
    Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cadherin switching in human prostate cancer progression.
    Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA.
    Cancer Res; 2000 Jul 01; 60(13):3650-4. PubMed ID: 10910081
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
    Zou W, Hu CH, Zhou JP.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):499-502. PubMed ID: 12658921
    [Abstract] [Full Text] [Related]

  • 9. Molecular biology of prostate cancer.
    Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD, Ewing CM.
    Semin Oncol; 1994 Oct 28; 21(5):514-21. PubMed ID: 7939745
    [Abstract] [Full Text] [Related]

  • 10. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep 28; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K, Tomita K, Schalken JA, Kume H, Yamaguchi T, Muto S, Horie S, Kitamura T.
    Eur Urol; 2006 May 28; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [Abstract] [Full Text] [Related]

  • 12. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M, Ishida H, Shindo T, Niwa S, Kino M, Kawamura K, Kamiya N, Imamoto T, Suzuki H, Hirokawa Y, Shiraishi T, Tanizawa T, Nakatani Y, Ichikawa T.
    Prostate; 2008 Dec 01; 68(16):1715-24. PubMed ID: 18781578
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R, Diaz LK, Laskin WB, Pins MR.
    J Urol; 2006 Dec 01; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [Abstract] [Full Text] [Related]

  • 14. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A, Louis J, Montlevier S, Peoch M, Pasquier D, Bosson JL, Rambeaud JJ, Seigneurin D.
    Invasion Metastasis; 1997 Dec 01; 17(3):124-37. PubMed ID: 9702939
    [Abstract] [Full Text] [Related]

  • 15. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schröder FH, van der Kwast TH, Bosman FT, van Dekken H.
    Lab Invest; 1997 Nov 01; 77(5):437-48. PubMed ID: 9389787
    [Abstract] [Full Text] [Related]

  • 16. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y.
    Clin Cancer Res; 2000 Feb 01; 6(2):460-6. PubMed ID: 10690524
    [Abstract] [Full Text] [Related]

  • 17. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma.
    Nair KS, Naidoo R, Chetty R.
    Hum Pathol; 2006 Feb 01; 37(2):125-34. PubMed ID: 16426911
    [Abstract] [Full Text] [Related]

  • 18. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J, Hirasawa K, Bostwick DG, Bergstralh EJ, Slezak JM, Anderl KL, Borell TJ, Lieber MM, Jenkins RB.
    Mod Pathol; 2002 Jan 01; 15(1):35-44. PubMed ID: 11796839
    [Abstract] [Full Text] [Related]

  • 19. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J, Ikeguchi M, Nakamura S, Kaibara N.
    J Exp Clin Cancer Res; 2002 Mar 01; 21(1):65-71. PubMed ID: 12071532
    [Abstract] [Full Text] [Related]

  • 20. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
    Syrigos KN, Harrington K, Waxman J, Krausz T, Pignatelli M.
    J Urol; 1998 Nov 01; 160(5):1889-93. PubMed ID: 9783980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.